(Q39292187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Investigation of cytotoxicity of negative control peptides versus bioactive peptides on skin cancer and normal cells: a comparative study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Elena Pirogova

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

5

Taghrid S Istivan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

Nahlah M Almansour

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

3

Peter J Coloe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

Future Medicinal Chemistry

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1553-1565

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22917245%20AND%20SRC:MED&resulttype=core&format=json

A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

11 February 2020

cites work

1 reference

Advances in methods for therapeutic peptide discovery, design and development

21 January 2018

1 reference

Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades.

21 January 2018

1 reference

Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides

21 January 2018

1 reference

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

21 January 2018

1 reference

21 January 2018

1 reference

Oncolytic viruses: programmable tumour hunters

21 January 2018

1 reference

21 January 2018

1 reference

Oncolytic viral therapies

21 January 2018

1 reference

Recent progress in the battle between oncolytic viruses and tumours

21 January 2018

1 reference

Vaccinia as a vector for gene delivery

21 January 2018

1 reference

Oncolytic viral therapies - the clinical experience

21 January 2018

1 reference

21 January 2018

1 reference

Immune responses to myxoma virus

21 January 2018

1 reference

Myxoma virus in the European rabbit: interactions between the virus and its susceptible host

21 January 2018

1 reference

Absence of serological evidence of myxoma virus infection in humans exposed during an outbreak of myxomatosis

21 January 2018

1 reference

Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein

21 January 2018

1 reference

Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells

21 January 2018

1 reference

Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.

21 January 2018

1 reference

Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells

21 January 2018

1 reference

Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer

21 January 2018

1 reference

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

21 January 2018

1 reference

Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells

21 January 2018

1 reference

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas

21 January 2018

1 reference

Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.

21 January 2018

1 reference

Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors

21 January 2018

1 reference

Biological effects of a de novo designed myxoma virus peptide analogue: evaluation of cytotoxicity on tumor cells.

21 January 2018

1 reference

Virtual spectroscopy for fun and profit

21 January 2018

1 reference

Bioactive peptide design using the Resonant Recognition Model

21 January 2018

1 reference

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

Characterization of a haemolytic phospholipase A(2) activity in clinical isolates of Campylobacter concisus

21 January 2018

1 reference

Estimating the number of viable animal cells in multi-well cultures based on their lactate dehydrogenase activities

21 January 2018

1 reference

Manufacturing peptides as active pharmaceutical ingredients.

21 January 2018

1 reference

Apoptosis: a review of programmed cell death

21 January 2018

1 reference

Cell death: the significance of apoptosis

21 January 2018

1 reference

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by cellular PIKE-A

21 January 2018

1 reference